Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom

Stock Information for Novavax Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Novavax Inc.

Endo Announces Fill-Finish Manufacturing and Services Agreement for Novavax COVID-19 Vaccine Candidate
Gov. Hogan, Novavax' Erck, & BIO's Dr. McMurry-Heath Toured Novavax Labs and Discussed Progress on COVID-19 Vaccine
Novavax Announces COVID-19 Vaccine Manufacturing Agreement with Serum Institute of India, Increasing Novavax' Global Production Capacity to Over 2 Billion Doses Annually
Novavax to Participate in Upcoming Investor Conferences
Biopharma Leaders Unite to Stand with Science
Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa
Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax' COVID-19 Vaccine Candidate
AGC Biologics Expands Partnership with Novavax

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.